Difficulty: Medium
Average Score: 72%
Testbank
A patient diagnosed with acute myelogenous leukemia has just been admitted to the oncology unit. When writing this patients care plan, what potential complication should the nurse address?
Correct answer
B
Rationale
Hemorrhage is a potential complication that the nurse should address in the care plan for a patient with acute myelogenous leukemia.
Patients with acute myelogenous leukemia are at high risk for bleeding due to thrombocytopenia, which is a common consequence of the disease and its treatment. The impaired production of platelets can lead to spontaneous bleeding, making it crucial for the nurse to monitor for signs of hemorrhage and implement appropriate interventions to manage this risk.
A: Pancreatitis is not a typical complication associated with acute myelogenous leukemia, as it primarily affects the blood and bone marrow rather than the pancreas.
C: Arteritis does not directly relate to acute myelogenous leukemia, as this condition primarily involves blood cell production rather than inflammatory processes affecting blood vessels.
D: Liver dysfunction is not a primary complication of acute myelogenous leukemia, although it can occur in some patients; it is less immediate compared to the risk of hemorrhage.
Patients with acute myelogenous leukemia are at high risk for bleeding due to thrombocytopenia, which is a common consequence of the disease and its treatment. The impaired production of platelets can lead to spontaneous bleeding, making it crucial for the nurse to monitor for signs of hemorrhage and implement appropriate interventions to manage this risk.
A: Pancreatitis is not a typical complication associated with acute myelogenous leukemia, as it primarily affects the blood and bone marrow rather than the pancreas.
C: Arteritis does not directly relate to acute myelogenous leukemia, as this condition primarily involves blood cell production rather than inflammatory processes affecting blood vessels.
D: Liver dysfunction is not a primary complication of acute myelogenous leukemia, although it can occur in some patients; it is less immediate compared to the risk of hemorrhage.